The University of Alabama at Birmingham is accelerating spatial biology research with announcement of $160,000 worth of ...

AI-powered digital pathology specialist PathAI, based in Boston in the US, said that AIM-NASH AI Assist is designed to assist ...

Gavreto is recommended as a first-line treatment for metastatic RET fusion-positive, metastatic non-small cell lung cancer, ...

EMA’s human medicines committee qualifies first AI tool to diagnose inflammatory liver disease in biopsy samples: Amsterdam, The Netherlands Saturday, March 22, 2025, 16:00 Hrs ...

The gene expression and spatial distribution of the immune cells in the tumour microenvironment indicates whether liver cancer will ... is in the Department of Pathology and Neuropathology ...

Radiotherapy may leave behind microscopic cancer even when scan images suggest the tumour is gone, and this “residual disease ...

The U.S. Food and Drug Administration's (FDA) Biomarker Qualification Program (BQP) is currently reviewing C-Path's Full Qualification Package (FQP) to qualify GLDH as a liver safety biomarker. The ...

Researchers provide a conceptual overview of liver vasomics, including the classification of vascular phenotypes in the liver ...

Radiotherapy, especially a form known as stereotactic ablative radiotherapy (SABR), is widely used to treat cancers in the ...

Chinese scientists and their counterparts from Singapore have developed a highly accurate scoring system to predict the risk of recurrence for a serious form of liver cancer called ... of immune cells ...

Discover why Gyre Therapeutics is rated 'Hold' amid volatile stock behavior, uncertain long-term prospects, and pending Phase ...